CL Stock Chart & Stats
CHF75.13
CHF0.98(1.32%)
At close: 4:00 PM EDT
CHF75.13
CHF0.98(1.32%)
Day’s Range― - ―
52-Week RangeCHF60.28 - CHF77.39
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
CHF59.09B
Enterprise ValueCHF80.24K
Total Cash (Recent Filing)CHF1.37B
Total Debt (Recent Filing)CHF7.86B
Price to Earnings (P/E)35.9
Beta0.19
Next Earnings
Oct 23, 2026EPS Estimate
0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.54
Shares Outstanding800,189,330
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.19
Price to Book (P/B)1.18K
Price to Sales (P/S)3.14
P/FCF Ratio17.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF80.68Price Target Upside7.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
EPS Forecast (FY)3.12
Revenue Forecast (FY)CHF17.32B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GenerationConsistent, large free cash flow (TTM ~$3.86B) funds dividends, buybacks and debt service, enabling durable capital allocation. Strong operating cash flow (~$4.46B) supports investment in brands, innovation and working capital, and provides a buffer through cycles.
Emerging Markets Revenue StrengthBroad-based organic growth led by emerging markets (mid-single digits) and standout country performance (India double-digits) diversifies revenue sources. Geographic breadth reduces dependence on any single economy and supports more stable long-term top-line growth.
Hill's Premium Pet FranchiseHill's operates as a premium, higher-margin franchise with therapeutic and wet segments growing and e-commerce momentum. Its pricing power, clinical positioning and category mix offer durable structural tailwinds and a stable profit contributor over time.
Bears Say
High Financial LeverageVery high leverage and an unusually small equity base materially reduce financial flexibility. Elevated debt-to-equity (~33x) raises refinancing, covenant and interest-rate sensitivity risks, limiting the company's ability to invest or absorb earnings shocks over the medium term.
Margin Compression Vs. 2024Profitability has meaningfully cooled versus 2024, with TTM net margin declining to ~9.7% from ~14.4%. Sustained margin pressure reduces internal funding for growth and shareholder returns, and increases vulnerability to raw material and tariff cost swings.
Channel & Private-Label HeadwindsRetail destocking (shipments down ~3% vs consumption flat) and private-label gains in pet (≈200bps volume hit) create structural headwinds to volume and visibility. These channel dynamics can persist, pressuring organic growth and forcing continued promotional or trade spend.
Colgate-Palmolive News
CL FAQ
What was Colgate-Palmolive’s price range in the past 12 months?
Colgate-Palmolive lowest stock price was CHF60.28 and its highest was CHF77.39 in the past 12 months.
What is Colgate-Palmolive’s market cap?
Colgate-Palmolive’s market cap is CHF59.09B.
When is Colgate-Palmolive’s upcoming earnings report date?
Colgate-Palmolive’s upcoming earnings report date is Oct 23, 2026 which is in 76 days.
How were Colgate-Palmolive’s earnings last quarter?
Colgate-Palmolive released its earnings results on Jul 31, 2026. The company reported CHF0.8 earnings per share for the quarter, beating the consensus estimate of CHF0.765 by CHF0.035.
Is Colgate-Palmolive overvalued?
According to Wall Street analysts Colgate-Palmolive’s price is currently Undervalued.
Does Colgate-Palmolive pay dividends?
Colgate-Palmolive does not currently pay dividends.
What is Colgate-Palmolive’s EPS estimate?
Colgate-Palmolive’s EPS estimate is 0.75.
How many shares outstanding does Colgate-Palmolive have?
Colgate-Palmolive has 800,189,330 shares outstanding.
What happened to Colgate-Palmolive’s price movement after its last earnings report?
Colgate-Palmolive reported an EPS of CHF0.8 in its last earnings report, beating expectations of CHF0.765. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Colgate-Palmolive?
Currently, no hedge funds are holding shares in CH:CL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Colgate-Palmolive Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
CHF80.68 (7.39% Upside)
CHF80.68 (7.39% Upside)
Blogger Sentiment
Bullish
CH:CL Sentiment 71%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth CHF1.1M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.16%
12-Months-Change
Fundamentals
Return on Equity
2.30%
Trailing 12-Months
Asset Growth
-3.89%
Trailing 12-Months
Company Description
Colgate-Palmolive
Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.g., toothpastes, toothbrushes, mouthwashes), personal care (e.g., bar and liquid soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, skin health items), and home care solutions (e.g., dishwashing detergents, fabric conditioners, household cleaners). These products are distributed through various channels, including traditional and online retailers, wholesalers, and distributors, under well-known brand names such as Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly. Furthermore, this segment supplies specialized pharmaceutical products to dentists and other professionals in oral healthcare. Conversely, the Pet Nutrition segment focuses on providing specialized pet food. This includes everyday nutritional options marketed under the Hill's Science Diet brand, as well as therapeutic diets designed to assist in managing various health conditions in dogs and cats, sold under the Hill's Prescription Diet brand. Distribution for these pet nutrition items occurs via pet supply stores, veterinary clinics, and online retail platforms. Established in 1806, Colgate-Palmolive Company maintains its corporate headquarters in New York, New York.
CL Company Deck
CL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated a predominantly constructive operating performance — broad-based organic growth across divisions, meaningful gross margin expansion, improved guidance, strong free cash flow (+18%) and sizable shareholder returns ($1.4B). Hill's and emerging markets were notable growth drivers, and management is increasing investment in advertising, innovation and AI. Offsetting these positives are persistent macro and category headwinds: U.S. softness and volatility, retailer inventory destocking (shipments down ~3%), private-label pressure in pet (-200 bps impact), and the risk of higher raw material and tariff costs in H2. Management emphasized prudent guidance and specific remedial actions for the U.S. business while citing confidence in the global operating model.View all CH:CL earnings summariesCL Net sales Breakdown
77.37% Oral, Personal and Home Care
22.63% Pet Nutrition

CL Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
CHF80.68
▲(7.39% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month









